gimli
HCG stock analysis context
HEALTHCARE GLOB. ENT. Stock Context for AI Screening
HEALTHCARE GLOB. ENT. LTD is a small-cap stock in Healthcare. This page summarizes key screening signals for HEALTHCARE GLOB. ENT., including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.
Ask Gimli about HCGPrice
₹654.30
1M return
+13.14%
3M return
+11.16%
Market cap
₹9,768.84 cr
PE
515.51
ROE
+2.04%
RSI
65.30
Turnover
₹26.18 cr
Why it can matter in screens
- Momentum: HCG is above 50DMA, above 200DMA; RSI is 65.30.
- Returns: 1M +13.14%, 3M +11.16%, 6M -9.62%.
- Liquidity: latest turnover is ₹26.18 cr.
- Valuation: PE 515.51, PB n/a, ROE +2.04%, ROCE +8.43%.
- Growth: 3Y sales CAGR +16.74%, 3Y profit CAGR -6.15%.
Try these prompts
- Analyze HEALTHCARE GLOB. ENT. with valuation, momentum and industry peers
- Compare HCG with other Healthcare stocks
- Show small-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare HCG with other Healthcare stocks
Data snapshot: 2026-05-22. Not investment advice.